Practical Dermatology

?? ?? UPDATES IN ATOPIC DERMATITIS: New research in atopic dermatitis is focusing on anti-OX40 ligand antibodies, aiming to modulate key inflammatory pathways. Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, elaborates on amlitelimab in adult patients with moderate-to-severe atopic dermatitis, and how this novel approach could add to treatment options for patients with moderate to severe AD. Watch the video ?? https://lnkd.in/evv8B8r6 #AtopicDermatitis #DermatologyInnovation #ClinicalTrials #InflammatoryDiseases #PatientCareNew research in atopic dermatitis is focusing on anti-OX40 ligand antibodies, aiming to modulate key inflammatory pathways. Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, elaborates on amlitelimab in adult patients with moderate-to-severe atopic dermatitis, and how this novel approach could add to treatment options for patients with moderate to severe AD. Watch the video ?? https://lnkd.in/evv8B8r6 #AtopicDermatitis #DermatologyInnovation #ClinicalTrials #InflammatoryDiseases #PatientCare

?? ???? SPOTLIGHT ON VULVOVAGINAL DERM: Audrey Rutherford MD's path to specializing in vulvovaginal dermatology was a draw at the 2024 Society of Dermatology Physician Associates (SDPA) annual meeting in Las Vegas. Dr. Rutherford emphasized the importance of addressing these sensitive and under-discussed conditions in paving the way for better patient outcomes. Watch the video ?? https://lnkd.in/e-a-7VPA #SDPA2024 #dermatology #vulvovaginalhealth #specializeddermatology #skin #womenshealth

?? ?? DERMWIRE TV: In this week's edition of DermWire TV, the FDA approves BIMZELX? (bimekizumab-bkzx) HCP for the treatment of moderate to severe hidradenitis suppurativa; the Agency also agreed to review the resubmission of DUPIXENT? (dupilumab) HCP for the treatment of CSU; and the president of Merz Aesthetics, North America, discusses trends in the aesthetic market. Watch the full report here ?? https://lnkd.in/e-H3uUQ9 #aesthetics #dermatology #skin #Bimzelx #Dupixent #dupilumab

?? ?? ON TRANSITIONING TO INDUSTRY, AND MORE: Practical Dermatology chats with Sara M. Wilchowski, DMSc, PA-C about her meeting presentation at the 2024 Society of Dermatology Physician Associates (SDPA) annual meeting, which offered a dual focus: her transition from clinical dermatology to an industry role, and the expanding potential of nutraceuticals in patient care. Get her key takeaways here ?? https://lnkd.in/e6Dir3iP #SDPA2024 #dermatology #nutraceuticals #professionaldevelopment #skin

???? ?? GIVING YOUR ALL FOR YOUR PATIENTS: Dermatologist Hilary Baldwin, M.D. talks with Practical Dermatology about her lectures at the 2024 Society of Dermatology Physician Associates (SDPA) annual meeting in Las Vegas covering acne and keloid management, as well as practical solutions for practitioners and some best practices for enhancing the quality of patient interactions. Watch the video ?? https://lnkd.in/e6qzmY3f #SDPA2024 #dermatology #acne #keloids #skin #professionaldevelopment

?? ?? ?? DUPILUMAB REVIEW: DUPIXENT? (dupilumab) HCP has emerged as a leading therapy for moderate-to-severe atopic dermatitis. In a new literature review of more than 60 real-world studies, data showed long-term survival rates of 80–90% over 3 years. Read the full story ? https://lnkd.in/gxq5NUDB #dermatology #atopicdermatitis #dupilumab #skin

? ?? ATOPIC DERM PEARLS: Dr. Matthew Zirwas discusses his passion for managing atopic dermatitis and shares key strategies for patient care at the Society of Dermatology Physician Associates (SDPA) annual conference in Las Vegas. Watch the video ?? ? https://lnkd.in/gjg8DD9s #SDPA2024 #SDPAconference #dermatology #atopicdermatitis #skin

?? ?? SUPPLEMENT STRATEGIES: Strategic supplement use can enhance dermatology care—but where to start? Sara M. Wilchowski, DMSc, PA-C, shared some of her insights with colleagues in her presentation, “Strategic Supplement Strategies for the Derm PA” from Society of Dermatology Physician Associates (SDPA)'s 22nd?Annual Fall Dermatology Conference in Las Vegas. Read the session coverage: ? https://lnkd.in/gNd7sTz9 #dermatology #PAinsights #supplements #SDPA

?? NEW APPROVAL: The FDA has approved BIMZELX? (bimekizumab-bkzx) HCP from UCB for adults with moderate-to-severe hidradenitis suppurativa (HS), making it the first treatment to selectively inhibit both interleukin 17A (IL-17A) and interleukin 17F (IL-17F). https://lnkd.in/e6tdnVch

?? THE LATEST IN EXOSOMES: Practical Dermatology talks with Todd Schlesinger, MD, a dermatologist and Mohs surgeon, and a member of the Editorial Board, about the latest updates in exosomes and what to expect next. This video was recorded at the Science of Skincare Summit in Austin. Watch the video ?? ? https://lnkd.in/eRce5xCH #exosomes #skincare #skin #dermatology